Olema Pharmaceuticals (OLMA) Financials: Revenue & Earnings

OLMA price $7.17 +0.13 +1.91%

Ticker
OLMA
Price
$7.17
Change
+0.13 +1.91%
Market cap ?
$627.75M
P/E ?
-3.32
Dividend yield ?
0.00%
Beta ?
2.01
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
57
Quality
46
Growth
100

Stocklytics score rationale: value 57, quality 46, growth 100.

Financials

20182019202020212022202320242025
00000000

Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER)…

Fair value

OLMA fair value Not meaningful. Price $7.17.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare OLMA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.60—1.25M
2026-08-10-0.61-0.55——
2026-05-12-0.52-0.52——
2026-03-16-0.50-0.51——
2025-11-10-0.49-0.44——
2025-08-11-0.51-0.43——
2025-05-13-0.36-0.49——
2025-03-18-0.51-0.63——
2024-11-12-0.60-0.59——
2024-08-06-0.54-0.54——
2024-05-08-0.56-0.53——
2024-03-11-0.49-0.491.88M—
2023-11-07-0.48-0.51——
2023-08-08-0.49-0.73——
2023-05-09-0.70-0.66——
2023-03-09-0.65-0.65——
2022-11-08-0.57-0.79——
2022-08-09-0.82-0.65——
2022-05-09-0.58-0.57——
2022-02-28-0.54-0.51——
2021-11-10-0.45-0.47——
2021-08-10-0.42-0.39——
2021-05-11-0.39-0.28——
2021-03-17-0.50-0.18——
2020-11-19-0.17———
2020-09-30-0.21———
2020-03-31-0.12———
2019-12-31-0.07———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-01O'Byrne JasonBuy650.00K$10.566.86M
2026-08-11O'Byrne JasonOther0——
2026-07-24Harmon CyrusSell12.50K$11.71146.43K
2026-07-23Harmon CyrusSell12.50K$11.58144.74K
2026-06-18BVF PARTNERS L P/ILBuy29.50K$9.51280.55K
2026-06-18Harmon CyrusBuy29.50K$9.51280.55K
2026-06-18BUTITTA CYNTHIA MBuy29.50K$9.51280.55K
2026-06-18Garland J. ScottBuy29.50K$9.51280.55K
2026-06-18Hrustanovic GorjanBuy29.50K$9.51280.55K
2026-06-18CLARK IAN TBuy29.50K$9.51280.55K
2026-06-18Larson YiBuy29.50K$9.51280.55K
2026-06-18Horning SandraBuy29.50K$9.51280.55K
2026-06-18Raman PrakashBuy29.50K$9.51280.55K
2026-06-18RAPPAPORT ANDREWBuy29.50K$9.51280.55K
2026-06-18Graham G. WalmsleyBuy29.50K$9.51280.55K
2026-04-28Raman PrakashBuy24.15K$14.59352.35K
2026-04-28Raman PrakashBuy2.91K$14.5942.47K
2026-04-28Raman PrakashOther0——
2026-03-04Mitchell ShawnteSell25.00K$4.37109.25K
2026-03-04Mitchell ShawnteBuy25.00K$4.37109.25K
2026-03-04Mitchell ShawnteSell24.77K$24.25600.60K
2026-03-04Mitchell ShawnteSell233$24.695.75K
2026-03-03Mitchell ShawnteSell15.00K$4.3765.55K
2026-03-03Mitchell ShawnteBuy15.00K$4.3765.55K
2026-03-03Mitchell ShawnteSell15.00K$23.01345.15K
2026-02-02Austin Sasha LuBuy29.25K$25.65750.26K
2026-02-02Austin Sasha LuBuy11.70K——
2026-02-02Zojwalla NaseemBuy250.00K$25.656.41M
2026-02-02Zojwalla NaseemBuy106.25K$25.652.73M
2026-02-02Myles David C.Buy250.00K$25.656.41M
2026-02-02Myles David C.Buy106.25K$25.652.73M
2026-02-02Mitchell ShawnteBuy220.00K$25.655.64M
2026-02-02Mitchell ShawnteBuy56.25K$25.651.44M
2026-02-02Bohen SeanBuy850.00K$25.6521.80M
2026-02-02Bohen SeanBuy275.00K$25.657.05M
2026-02-01Austin Sasha LuOther13.00K$2.4431.72K
2026-01-30Austin Sasha LuOther0——
2026-01-30Austin Sasha LuOther6.50K$4.8731.66K
2026-01-30Austin Sasha LuOther17.50K$3.4961.08K
2026-01-30Austin Sasha LuOther51.00K$15.25777.75K
2026-01-30Austin Sasha LuOther45.00K$4.37196.65K
2026-01-20Harmon CyrusSell10.00K$26.88268.80K
2026-01-15Kovacs Shane William CharlesSell100.00K$28.732.87M
2026-01-14Harmon CyrusSell3.49K$29.12101.60K
2026-01-14Myles David C.Buy50.00K$4.87243.50K
2026-01-14Myles David C.Sell15.00K$28.60428.91K
2026-01-14Myles David C.Sell35.00K$28.991.01M
2026-01-14Myles David C.Sell50.00K$4.87243.50K
2026-01-13Kovacs Shane William CharlesSell3.82K$28.01107.05K
2026-01-13Myles David C.Sell49.80K$27.601.37M
2026-01-13Myles David C.Sell200$28.495.70K
2026-01-13Myles David C.Sell50.00K$4.87243.50K
2026-01-12Myles David C.Sell10.00K$28.34283.40K
2025-12-26Bohen SeanSell8.50K——
2025-12-23Zojwalla NaseemSell50.00K$7.02351.00K
2025-12-23Zojwalla NaseemBuy50.00K$7.02351.00K
2025-12-23Zojwalla NaseemSell99.51K$27.662.75M
2025-12-22Harmon CyrusSell2.88K$28.5382.19K
2025-12-22Zojwalla NaseemSell7.18K$7.0250.42K
2025-12-22Zojwalla NaseemBuy7.18K$7.0250.42K
2025-12-22Zojwalla NaseemBuy42.82K$15.25652.97K
2025-12-22Zojwalla NaseemSell42.82K$15.25652.97K
2025-12-22Zojwalla NaseemSell100.00K$28.042.80M
2025-12-19CLARK IAN TBuy12.07K$4.0849.25K
2025-12-19CLARK IAN TBuy21.52K$7.84168.72K
2025-12-19CLARK IAN TSell29.90K$28.83862.13K
2025-12-19CLARK IAN TBuy21.52K$3.6177.69K
2025-12-19CLARK IAN TBuy209.69K$4.41923.89K
2025-12-19CLARK IAN TSell193.06K$29.715.74M
2025-12-19CLARK IAN TSell12.07K$4.0849.25K
2025-12-19CLARK IAN TSell41.84K$30.481.28M
2025-12-19CLARK IAN TSell21.52K$3.6177.69K
2025-12-19CLARK IAN TSell21.52K$7.84168.72K
2025-12-19CLARK IAN TSell209.69K$4.41923.89K
2025-12-19Myles David C.Sell1.23K$28.0834.40K
2025-12-19Myles David C.Sell43.73K$30.401.33M
2025-12-19Myles David C.Sell6.05K$31.39189.78K
2025-12-19Myles David C.Sell9.00K——
2025-12-19Zojwalla NaseemBuy40.00K$15.25610.00K
2025-12-19Zojwalla NaseemSell40.00K$15.25610.00K
2025-12-19Zojwalla NaseemSell57.08K$28.031.60M
2025-12-19Zojwalla NaseemSell12.92K$28.93373.80K
2025-12-08Kovacs Shane William CharlesSell75.00K——
2025-11-26Kovacs Shane William CharlesSell225.00K——
2025-11-25RAPPAPORT ANDREWSell35.87K$0.3913.99K
2025-11-21RAPPAPORT ANDREWBuy35.87K$0.3913.99K
2025-11-21RAPPAPORT ANDREWSell35.87K$0.3913.99K
2025-09-18Harmon CyrusSell10.00K$8.3383.30K
2025-09-18Harmon CyrusSell3.09K$8.3225.68K
2025-09-16Harmon CyrusSell10.00K$8.0480.40K
2025-09-16Harmon CyrusSell1.91K$8.0815.47K
2025-06-11BVF PARTNERS L P/ILBuy24.15K$4.0898.53K
2025-06-11Larson YiBuy24.15K$4.0898.53K
2025-06-11Garland J. ScottBuy24.15K$4.0898.53K
2025-06-11Horning SandraBuy24.15K$4.0898.53K
2025-06-11CLARK IAN TBuy24.15K$4.0898.53K
2025-06-11Hrustanovic GorjanBuy24.15K$4.0898.53K
2025-06-11Graham G. WalmsleyBuy24.15K$4.0898.53K
2025-06-11Harmon CyrusBuy24.15K$4.0898.53K
2025-06-11BUTITTA CYNTHIA MBuy24.15K$4.0898.53K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 201, holders -18 vs prior quarter. Ownership 99.65%.

HolderSharesChangeChange %Value
FMR LLC12.14M1.76M+16.91%151.91M
PARADIGM BIOCAPITAL ADVISORS LP8.67M650.00K+8.10%108.47M
JUPITER TOPCO LLC7.09M7.09MNew88.80M
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC7.09M-387.99K-5.19%88.64M
BLACKROCK, INC.6.71M1.06M+18.80%84.00M
BVF INC/IL5.30M00.00%66.25M
SIREN, L.L.C.4.86M100.00K+2.10%60.76M
STATE STREET CORP4.32M378.23K+9.60%53.99M
VANGUARD CAPITAL MANAGEMENT LLC3.34M257.70K+8.36%41.80M
LOGOS GLOBAL MANAGEMENT LP3.21M00.00%40.14M
FRANKLIN TEMPLETON INC2.35M1.13M+92.75%29.39M
CORMORANT ASSET MANAGEMENT, LP2.15M1.65M+330.00%26.90M
MORGAN STANLEY1.83M616.58K+50.72%22.92M
GEODE CAPITAL MANAGEMENT, LLC1.82M274.61K+17.78%22.76M
VANGUARD PORTFOLIO MANAGEMENT LLC1.66M1.07M+180.46%20.81M
GOLDMAN SACHS GROUP INC1.57M1.40M+852.60%19.62M
DEEP TRACK CAPITAL, LP1.50M1.50MNew18.77M
DIMENSIONAL FUND ADVISORS LP1.42M334.10K+30.87%17.72M
LIGHTSPEED MANAGEMENT COMPANY, L.L.C.1.36M00.00%16.95M
KINGDON CAPITAL MANAGEMENT, L.L.C.1.20M345.00K+40.35%15.01M
TWO SIGMA INVESTMENTS, LP1.13M-37.99K-3.25%14.15M
POINT72 ASSET MANAGEMENT, L.P.1.07M999.84K+1406.11%13.40M
DUQUESNE FAMILY OFFICE LLC986.83K00.00%12.35M
DEFILADE CAPITAL MANAGEMENT, L.P.924.76K-579.78K-38.54%11.57M
AMERIPRISE FINANCIAL INC840.65K840.65KNew10.52M

Earnings and financials

Olema Pharmaceuticals, Inc. (OLMA) trades at $7.17, with a market cap of $627.75M and a trailing P/E of -3.32. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
00000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Olema Pharmaceuticals (OLMA) Financials: Revenue & Earnings

OLMA$7.17+0.13 +1.91%

$627.75M

Market Cap

-3.32

P/E

—

Forward P/E

68

Score

Price History